Pakistan's Zardari in UK, meets girl shot by Taliban
BIRMINGHAM, England (Reuters) - Pakistan's President Asif Zardari held a private meeting on Saturday with Malala Yousufzai, the teenage Pakistani schoolgirl shot by the Taliban after advocating education for girls, at the British hospital where she is being treated.
Yousufzai, who was shot in the head at close range by the Pakistan Taliban in October as she left school in the Swat valley, was flown for specialist treatment at the hospital which has treated hundreds of British soldiers wounded in Afghanistan.
World leaders have since pledged to support her campaign and more than 250,000 people have signed online petitions calling for her to be nominated for a Nobel Peace Prize for her activism.
Yousufzai was a "remarkable girl and a credit to Pakistan", Zardari said in a brief statement issued by the hospital, after he and his daughter Asifa Bhutto held a five minute meeting with the teenager, her father and two brothers.
During his visit to the Queen Elizabeth hospital in Birmingham in the English midlands, Zardari was briefed on Yousufzai's condition. He left without speaking to media.
The hospital said on Saturday she was "well". It has previously said she was recovering after suffering fractures to her skull and jawbone, but would need reconstructive surgery.
(Writing by Tim Castle; Editing by Sophie Hares)
- Tweet this
- Share this
- Digg this
- Pakistani family sentenced to death over "honour killing" outside court
- UPDATE 3-Residents in western New York call snow worst in memory
- Alumnus dead after opening fire at Florida State University, wounding 3 |
- Kotak bank buys ING Vysya in record $2.4 billion share deal
- Mike Nichols, award-winning American director, dies at 83
Self-styled religious leader Satguru Rampalji Maharaj was charged on Thursday with sedition and waging war against the state after a days-long siege of his sprawling compound ended in his arrest along with 450 hardcore followers. Full Article
U.S. court overturns bid by Ranbaxy to block launch of rival generic drugs. Full Article